Connection

Konstantinos Syrigos to Cohort Studies

Back to Details
This is a "connection" page, showing publications Konstantinos Syrigos has written about Cohort Studies.
Konstantinos Syrigos
Connection Strength
0.079
Cohort Studies
  1. Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study. Oncologist. 2018 11; 23(11):1372-1381.
    View in: PubMed
    Score: 0.034
  2. Pulmonary hypertension after pneumonectomy for lung cancer. Asian Cardiovasc Thorac Ann. 2014 Nov; 22(9):1072-9.
    View in: PubMed
    Score: 0.025
  3. Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations. J Thorac Oncol. 2018 12; 13(12):1884-1896.
    View in: PubMed
    Score: 0.009
  4. Programmed death ligand-1 expression in non-small cell lung cancer. Lab Invest. 2014 Jan; 94(1):107-16.
    View in: PubMed
    Score: 0.006
  5. High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma. Clin Cancer Res. 2009 Jun 15; 15(12):4157-64.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.